View ValuationNipro 将来の成長Future 基準チェック /16Nipro利益と収益がそれぞれ年間16.6%と3.8%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に9.2% 22.1%なると予測されています。主要情報16.6%収益成長率22.14%EPS成長率Medical Equipment 収益成長13.3%収益成長率3.8%将来の株主資本利益率9.19%アナリストカバレッジLow最終更新日17 Jun 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBuy Or Sell Opportunity • Jun 16Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to €8.95. The fair value is estimated to be €7.41, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 6.6% over the last 3 years. Earnings per share has grown by 26%. For the next 3 years, revenue is forecast to grow by 3.8% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.お知らせ • Jun 03Nipro Corporation to Report Q1, 2027 Results on Aug 10, 2026Nipro Corporation announced that they will report Q1, 2027 results on Aug 10, 2026お知らせ • May 12Nipro Corporation, Annual General Meeting, Jun 26, 2026Nipro Corporation, Annual General Meeting, Jun 26, 2026.お知らせ • Mar 09Nipro Corporation to Report Fiscal Year 2026 Final Results on May 12, 2026Nipro Corporation announced that they will report fiscal year 2026 final results on May 12, 2026お知らせ • Dec 17Nipro Corporation to Report Q3, 2026 Results on Feb 09, 2026Nipro Corporation announced that they will report Q3, 2026 results on Feb 09, 2026お知らせ • Sep 30Nipro Corporation to Report Q2, 2026 Results on Nov 10, 2025Nipro Corporation announced that they will report Q2, 2026 results on Nov 10, 2025お知らせ • Jun 03Nipro Corporation to Report Q1, 2026 Results on Aug 08, 2025Nipro Corporation announced that they will report Q1, 2026 results on Aug 08, 2025お知らせ • May 12+ 3 more updatesNipro Corporation, Annual General Meeting, Jun 26, 2025Nipro Corporation, Annual General Meeting, Jun 26, 2025.お知らせ • Mar 04Nipro Corporation to Report Fiscal Year 2025 Results on May 12, 2025Nipro Corporation announced that they will report fiscal year 2025 results at 12:00 PM, Tokyo Standard Time on May 12, 2025お知らせ • Dec 03Nipro Corporation to Report Q3, 2025 Results on Feb 07, 2025Nipro Corporation announced that they will report Q3, 2025 results on Feb 07, 2025Reported Earnings • Nov 10Second quarter 2025 earnings released: JP¥15.31 loss per share (vs JP¥35.76 profit in 2Q 2024)Second quarter 2025 results: JP¥15.31 loss per share (down from JP¥35.76 profit in 2Q 2024). Revenue: JP¥159.6b (up 9.9% from 2Q 2024). Net loss: JP¥2.50b (down 143% from profit in 2Q 2024). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Sep 20Upcoming dividend of JP¥12.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 42% but the company is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of German dividend payers (4.8%). Higher than average of industry peers (1.9%).お知らせ • Aug 29Nipro Corporation to Report Q2, 2025 Results on Nov 08, 2024Nipro Corporation announced that they will report Q2, 2025 results on Nov 08, 2024Buy Or Sell Opportunity • Aug 06Now 22% overvaluedOver the last 90 days, the stock has fallen 2.7% to €7.15. The fair value is estimated to be €5.88, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.8% over the last 3 years. Earnings per share has declined by 25%. For the next 3 years, revenue is forecast to grow by 3.8% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.Declared Dividend • Jul 11Final dividend of JP¥12.00 announcedShareholders will receive a dividend of JP¥12.00. Ex-date: 27th September 2024 Payment date: 4th December 2024 Dividend yield will be 168%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (29% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 2.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 36% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Jun 02Nipro Corporation to Report Q1, 2025 Results on Aug 08, 2024Nipro Corporation announced that they will report Q1, 2025 results on Aug 08, 2024Reported Earnings • May 13Full year 2024 earnings released: EPS: JP¥68.11 (vs JP¥28.05 in FY 2023)Full year 2024 results: EPS: JP¥68.11 (up from JP¥28.05 in FY 2023). Revenue: JP¥586.8b (up 7.6% from FY 2023). Net income: JP¥11.1b (up 143% from FY 2023). Profit margin: 1.9% (up from 0.8% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.お知らせ • May 12Nipro Corporation, Annual General Meeting, Jun 26, 2024Nipro Corporation, Annual General Meeting, Jun 26, 2024.Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 2.1%. Lower than top quartile of German dividend payers (5.0%). Higher than average of industry peers (1.6%).お知らせ • Mar 01Nipro Corporation to Report Fiscal Year 2024 Results on May 10, 2024Nipro Corporation announced that they will report fiscal year 2024 results on May 10, 2024Reported Earnings • Feb 11Third quarter 2024 earnings released: EPS: JP¥16.54 (vs JP¥4.35 in 3Q 2023)Third quarter 2024 results: EPS: JP¥16.54 (up from JP¥4.35 in 3Q 2023). Revenue: JP¥153.3b (up 5.0% from 3Q 2023). Net income: JP¥2.70b (up 280% from 3Q 2023). Profit margin: 1.8% (up from 0.5% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.お知らせ • Nov 29Nipro Corporation to Report Q3, 2024 Results on Feb 08, 2024Nipro Corporation announced that they will report Q3, 2024 results on Feb 08, 2024Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: JP¥35.76 (vs JP¥5.99 in 2Q 2023)Second quarter 2024 results: EPS: JP¥35.76 (up from JP¥5.99 in 2Q 2023). Revenue: JP¥145.3b (up 9.7% from 2Q 2023). Net income: JP¥5.83b (up 497% from 2Q 2023). Profit margin: 4.0% (up from 0.7% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.Upcoming Dividend • Sep 21Upcoming dividend of JP¥10.00 per share at 2.0% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 05 December 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.8%). In line with average of industry peers (2.0%).お知らせ • Aug 27Nipro Corporation to Report Q2, 2024 Results on Nov 09, 2023Nipro Corporation announced that they will report Q2, 2024 results on Nov 09, 2023New Risk • Aug 10New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 106% The company is paying a dividend despite having no free cash flows. Dividend yield: 2.2% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (1.8% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 106% Paying a dividend despite having no free cash flows. Minor Risk Profit margins are more than 30% lower than last year (0.6% net profit margin).Reported Earnings • Aug 10First quarter 2024 earnings released: EPS: JP¥25.13 (vs JP¥32.34 in 1Q 2023)First quarter 2024 results: EPS: JP¥25.13 (down from JP¥32.34 in 1Q 2023). Revenue: JP¥140.6b (up 9.9% from 1Q 2023). Net income: JP¥4.10b (down 22% from 1Q 2023). Profit margin: 2.9% (down from 4.1% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • May 28Nipro Corporation to Report Q1, 2024 Results on Aug 09, 2023Nipro Corporation announced that they will report Q1, 2024 results on Aug 09, 2023Reported Earnings • May 14Full year 2023 earnings released: EPS: JP¥28.05 (vs JP¥82.50 in FY 2022)Full year 2023 results: EPS: JP¥28.05 (down from JP¥82.50 in FY 2022). Revenue: JP¥545.2b (up 10% from FY 2022). Net income: JP¥4.57b (down 66% from FY 2022). Profit margin: 0.8% (down from 2.7% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Medical Equipment industry in Germany.お知らせ • May 13Nipro Corporation, Annual General Meeting, Jun 28, 2023Nipro Corporation, Annual General Meeting, Jun 28, 2023.Upcoming Dividend • Mar 23Upcoming dividend of JP¥8.50 per share at 2.2% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 29 June 2023. Payout ratio is a comfortable 22% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (4.7%). Higher than average of industry peers (1.7%).Reported Earnings • Feb 09Third quarter 2023 earnings released: EPS: JP¥4.35 (vs JP¥22.90 in 3Q 2022)Third quarter 2023 results: EPS: JP¥4.35 (down from JP¥22.90 in 3Q 2022). Revenue: JP¥146.0b (up 15% from 3Q 2022). Net income: JP¥710.0m (down 81% from 3Q 2022). Profit margin: 0.5% (down from 2.9% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Germany.お知らせ • Dec 01Nipro Corporation to Report Q3, 2023 Results on Feb 08, 2023Nipro Corporation announced that they will report Q3, 2023 results on Feb 08, 2023Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: JP¥5.99 (vs JP¥24.54 in 2Q 2022)Second quarter 2023 results: EPS: JP¥5.99 (down from JP¥24.54 in 2Q 2022). Revenue: JP¥132.4b (up 6.7% from 2Q 2022). Net income: JP¥977.0m (down 76% from 2Q 2022). Profit margin: 0.7% (down from 3.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Germany.Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: JP¥5.99 (vs JP¥24.54 in 2Q 2022)Second quarter 2023 results: EPS: JP¥5.99 (down from JP¥24.54 in 2Q 2022). Revenue: JP¥132.4b (up 6.7% from 2Q 2022). Net income: JP¥977.0m (down 76% from 2Q 2022). Profit margin: 0.7% (down from 3.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Medical Equipment industry in Germany.Upcoming Dividend • Sep 22Upcoming dividend of JP¥13.50 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 06 December 2022. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of German dividend payers (5.1%). Higher than average of industry peers (1.8%).お知らせ • Aug 28Nipro Corporation to Report Q2, 2023 Results on Nov 09, 2022Nipro Corporation announced that they will report Q2, 2023 results on Nov 09, 2022Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: JP¥32.34 (vs JP¥20.23 in 1Q 2022)First quarter 2023 results: EPS: JP¥32.34 (up from JP¥20.23 in 1Q 2022). Revenue: JP¥127.9b (up 8.4% from 1Q 2022). Net income: JP¥5.28b (up 60% from 1Q 2022). Profit margin: 4.1% (up from 2.8% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.3%, compared to a 7.4% growth forecast for the industry in Germany.Reported Earnings • May 13Full year 2022 earnings released: EPS: JP¥82.50 (vs JP¥87.12 in FY 2021)Full year 2022 results: EPS: JP¥82.50 (down from JP¥87.12 in FY 2021). Revenue: JP¥494.8b (up 8.6% from FY 2021). Net income: JP¥13.5b (down 5.3% from FY 2021). Profit margin: 2.7% (down from 3.1% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.7%, compared to a 7.2% growth forecast for the industry in Germany.お知らせ • May 13Nipro Corporation, Annual General Meeting, Jun 28, 2022Nipro Corporation, Annual General Meeting, Jun 28, 2022.お知らせ • Apr 08Nipro Corporation to Report Fiscal Year 2022 Results on May 11, 2022Nipro Corporation announced that they will report fiscal year 2022 results on May 11, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.50 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 28 June 2022. Payout ratio is a comfortable 35% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (3.6%). Higher than average of industry peers (1.1%).Reported Earnings • Feb 09Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥22.90 (down from JP¥30.07 in 3Q 2021). Revenue: JP¥127.2b (up 7.1% from 3Q 2021). Net income: JP¥3.74b (down 24% from 3Q 2021). Profit margin: 2.9% (down from 4.1% in 3Q 2021). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 4.8%, compared to a 12% growth forecast for the industry in Germany.Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥24.54 (vs JP¥14.99 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥124.1b (up 9.5% from 2Q 2021). Net income: JP¥4.00b (up 64% from 2Q 2021). Profit margin: 3.2% (up from 2.2% in 2Q 2021).Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.50 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 07 December 2021. Trailing yield: 2.5%. Lower than top quartile of German dividend payers (3.2%). Higher than average of industry peers (0.8%).お知らせ • Sep 09Nipro Corporation's Ordinary Shares to Be Deleted from Other OTCNipro Corporation's Ordinary Shares will be deleted from other OTC effective from September 8, 2021 due to Inactive Security.Reported Earnings • Aug 12First quarter 2022 earnings released: EPS JP¥20.23 (vs JP¥18.57 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2022 results: Revenue: JP¥118.0b (up 8.3% from 1Q 2021). Net income: JP¥3.30b (up 8.9% from 1Q 2021). Profit margin: 2.8% (in line with 1Q 2021).Reported Earnings • May 14Full year 2021 earnings released: EPS JP¥87.12 (vs JP¥75.30 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥455.6b (up 2.9% from FY 2020). Net income: JP¥14.2b (up JP¥26.5b from FY 2020). Profit margin: 3.1% (up from net loss in FY 2020).お知らせ • Mar 06Nipro Corporation to Report Fiscal Year 2021 Results on May 11, 2021Nipro Corporation announced that they will report fiscal year 2021 results on May 11, 2021Is New 90 Day High Low • Feb 18New 90-day high: €10.90The company is up 18% from its price of €9.25 on 19 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Medical Equipment industry, which is up 28% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.22 per share.Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS JP¥30.07 (vs JP¥30.49 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: JP¥118.8b (up 4.2% from 3Q 2020). Net income: JP¥4.90b (down 1.4% from 3Q 2020). Profit margin: 4.1% (down from 4.4% in 3Q 2020).Analyst Estimate Surprise Post Earnings • Feb 10Revenue misses expectationsRevenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to grow 7.6%, compared to a 14% growth forecast for the Medical Equipment industry in Germany.お知らせ • Dec 03Nipro Corporation to Report Q3, 2021 Results on Feb 08, 2021Nipro Corporation announced that they will report Q3, 2021 results on Feb 08, 2021Reported Earnings • Nov 17Second quarter 2021 earnings released: EPS JP¥14.99The company reported a poor second quarter result with weaker earnings and profit margins, although revenues were flat. Second quarter 2021 results: Revenue: JP¥113.3b (flat on 2Q 2020). Net income: JP¥2.44b (down 21% from 2Q 2020). Profit margin: 2.2% (down from 2.7% in 2Q 2020). The decrease in margin was driven by higher expenses.Analyst Estimate Surprise Post Earnings • Nov 17Revenue misses expectationsRevenue missed analyst estimates by 5.6%. Over the next year, revenue is forecast to grow 7.2%, compared to a 13% growth forecast for the Medical Equipment industry in Germany.Reported Earnings • Nov 11Second quarter 2021 earnings released: EPS JP¥14.99The company reported a poor second quarter result with weaker earnings and profit margins, although revenues were flat. Second quarter 2021 results: Revenue: JP¥113.3b (flat on 2Q 2020). Net income: JP¥2.44b (down 21% from 2Q 2020). Profit margin: 2.2% (down from 2.7% in 2Q 2020). The decrease in margin was driven by higher expenses.Is New 90 Day High Low • Nov 11New 90-day high: €11.50The company is up 21% from its price of €9.50 on 13 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Medical Equipment industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.26 per share.Is New 90 Day High Low • Oct 27New 90-day low: €8.85The company is down 7.0% from its price of €9.50 on 28 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.45 per share.お知らせ • Aug 23Nipro Corporation to Report Q2, 2021 Results on Nov 09, 2020Nipro Corporation announced that they will report Q2, 2021 results on Nov 09, 2020業績と収益の成長予測DB:5FA - アナリストの将来予測と過去の財務データ ( )JPY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/2029758,96523,74324,91782,12653/31/2028727,07219,14616,28172,47153/31/2027695,84913,75018,35058,00053/31/2026660,53813,504-7,63454,657N/A12/31/2025652,60915,203N/AN/AN/A9/30/2025649,95110,88917,46370,302N/A6/30/2025651,4145,758N/AN/AN/A3/31/2025644,5865,113-8,13368,461N/A12/31/2024626,9325,074N/AN/AN/A9/30/2024612,9371,307-30,86969,240N/A6/30/2024598,5839,636N/AN/AN/A3/31/2024586,78511,109-21,26772,936N/A12/31/2023578,03310,241N/AN/AN/A9/30/2023570,7258,253-49,13825,407N/A6/30/2023557,9013,398N/AN/AN/A3/31/2023545,1994,574-74,44010,395N/A12/31/2022531,7349,379N/AN/AN/A9/30/2022513,00812,404-34,24046,398N/A6/30/2022504,68015,430N/AN/AN/A3/31/2022494,78913,455-11,58968,214N/A12/31/2021483,83114,870N/AN/AN/A9/30/2021475,42516,039-8,86168,386N/A6/30/2021464,63514,480N/AN/AN/A3/31/2021455,55914,20914,91166,093N/A12/31/2020446,879-12,762N/AN/AN/A9/30/2020442,102-12,694-6,35045,200N/A6/30/2020441,680-12,044N/AN/AN/A3/31/2020442,516-12,281-20,69737,246N/A12/31/2019441,80813,142N/AN/AN/A9/30/2019440,74210,407N/A36,984N/A6/30/2019432,95910,246N/AN/AN/A3/31/2019426,39912,136N/A41,362N/A12/31/2018422,8407,857N/AN/AN/A9/30/2018415,81911,162N/A39,660N/A6/30/2018405,04612,269N/AN/AN/A3/31/2018395,39711,829N/A41,046N/A12/31/2017383,38111,099N/AN/AN/A9/30/2017370,02116,705N/A38,635N/A6/30/2017364,12715,375N/AN/AN/A3/31/2017359,69911,346N/A33,472N/A12/31/2016362,77619,821N/AN/AN/A9/30/2016364,70116,995N/A36,509N/A6/30/2016367,67716,027N/AN/AN/A3/31/2016366,65019,718N/A29,934N/A12/31/2015359,04411,918N/AN/AN/A9/30/2015350,11312,646N/A34,812N/A6/30/2015337,75715,122N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 5FAの予測収益成長率 (年間16.6% ) は 貯蓄率 ( 1.9% ) を上回っています。収益対市場: 5FAの収益 ( 16.6% ) German市場 ( 16.8% ) よりも低い成長が予測されています。高成長収益: 5FAの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 5FAの収益 ( 3.8% ) German市場 ( 6.5% ) よりも低い成長が予測されています。高い収益成長: 5FAの収益 ( 3.8% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 5FAの 自己資本利益率 は、3年後には低くなると予測されています ( 9.2 %)。成長企業の発掘7D1Y7D1Y7D1YHealthcare 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/28 01:29終値2026/06/26 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nipro Corporation 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13 アナリスト機関Masahiro NakanomyoBarclaysYuki YamazakiDaiwa Securities Co. Ltd.Stephen BarkerJefferies LLC10 その他のアナリストを表示
Buy Or Sell Opportunity • Jun 16Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to €8.95. The fair value is estimated to be €7.41, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 6.6% over the last 3 years. Earnings per share has grown by 26%. For the next 3 years, revenue is forecast to grow by 3.8% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.
お知らせ • Jun 03Nipro Corporation to Report Q1, 2027 Results on Aug 10, 2026Nipro Corporation announced that they will report Q1, 2027 results on Aug 10, 2026
お知らせ • May 12Nipro Corporation, Annual General Meeting, Jun 26, 2026Nipro Corporation, Annual General Meeting, Jun 26, 2026.
お知らせ • Mar 09Nipro Corporation to Report Fiscal Year 2026 Final Results on May 12, 2026Nipro Corporation announced that they will report fiscal year 2026 final results on May 12, 2026
お知らせ • Dec 17Nipro Corporation to Report Q3, 2026 Results on Feb 09, 2026Nipro Corporation announced that they will report Q3, 2026 results on Feb 09, 2026
お知らせ • Sep 30Nipro Corporation to Report Q2, 2026 Results on Nov 10, 2025Nipro Corporation announced that they will report Q2, 2026 results on Nov 10, 2025
お知らせ • Jun 03Nipro Corporation to Report Q1, 2026 Results on Aug 08, 2025Nipro Corporation announced that they will report Q1, 2026 results on Aug 08, 2025
お知らせ • May 12+ 3 more updatesNipro Corporation, Annual General Meeting, Jun 26, 2025Nipro Corporation, Annual General Meeting, Jun 26, 2025.
お知らせ • Mar 04Nipro Corporation to Report Fiscal Year 2025 Results on May 12, 2025Nipro Corporation announced that they will report fiscal year 2025 results at 12:00 PM, Tokyo Standard Time on May 12, 2025
お知らせ • Dec 03Nipro Corporation to Report Q3, 2025 Results on Feb 07, 2025Nipro Corporation announced that they will report Q3, 2025 results on Feb 07, 2025
Reported Earnings • Nov 10Second quarter 2025 earnings released: JP¥15.31 loss per share (vs JP¥35.76 profit in 2Q 2024)Second quarter 2025 results: JP¥15.31 loss per share (down from JP¥35.76 profit in 2Q 2024). Revenue: JP¥159.6b (up 9.9% from 2Q 2024). Net loss: JP¥2.50b (down 143% from profit in 2Q 2024). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Sep 20Upcoming dividend of JP¥12.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 42% but the company is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of German dividend payers (4.8%). Higher than average of industry peers (1.9%).
お知らせ • Aug 29Nipro Corporation to Report Q2, 2025 Results on Nov 08, 2024Nipro Corporation announced that they will report Q2, 2025 results on Nov 08, 2024
Buy Or Sell Opportunity • Aug 06Now 22% overvaluedOver the last 90 days, the stock has fallen 2.7% to €7.15. The fair value is estimated to be €5.88, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.8% over the last 3 years. Earnings per share has declined by 25%. For the next 3 years, revenue is forecast to grow by 3.8% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
Declared Dividend • Jul 11Final dividend of JP¥12.00 announcedShareholders will receive a dividend of JP¥12.00. Ex-date: 27th September 2024 Payment date: 4th December 2024 Dividend yield will be 168%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (29% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 2.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 36% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 02Nipro Corporation to Report Q1, 2025 Results on Aug 08, 2024Nipro Corporation announced that they will report Q1, 2025 results on Aug 08, 2024
Reported Earnings • May 13Full year 2024 earnings released: EPS: JP¥68.11 (vs JP¥28.05 in FY 2023)Full year 2024 results: EPS: JP¥68.11 (up from JP¥28.05 in FY 2023). Revenue: JP¥586.8b (up 7.6% from FY 2023). Net income: JP¥11.1b (up 143% from FY 2023). Profit margin: 1.9% (up from 0.8% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
お知らせ • May 12Nipro Corporation, Annual General Meeting, Jun 26, 2024Nipro Corporation, Annual General Meeting, Jun 26, 2024.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 2.1%. Lower than top quartile of German dividend payers (5.0%). Higher than average of industry peers (1.6%).
お知らせ • Mar 01Nipro Corporation to Report Fiscal Year 2024 Results on May 10, 2024Nipro Corporation announced that they will report fiscal year 2024 results on May 10, 2024
Reported Earnings • Feb 11Third quarter 2024 earnings released: EPS: JP¥16.54 (vs JP¥4.35 in 3Q 2023)Third quarter 2024 results: EPS: JP¥16.54 (up from JP¥4.35 in 3Q 2023). Revenue: JP¥153.3b (up 5.0% from 3Q 2023). Net income: JP¥2.70b (up 280% from 3Q 2023). Profit margin: 1.8% (up from 0.5% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
お知らせ • Nov 29Nipro Corporation to Report Q3, 2024 Results on Feb 08, 2024Nipro Corporation announced that they will report Q3, 2024 results on Feb 08, 2024
Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: JP¥35.76 (vs JP¥5.99 in 2Q 2023)Second quarter 2024 results: EPS: JP¥35.76 (up from JP¥5.99 in 2Q 2023). Revenue: JP¥145.3b (up 9.7% from 2Q 2023). Net income: JP¥5.83b (up 497% from 2Q 2023). Profit margin: 4.0% (up from 0.7% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Sep 21Upcoming dividend of JP¥10.00 per share at 2.0% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 05 December 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.8%). In line with average of industry peers (2.0%).
お知らせ • Aug 27Nipro Corporation to Report Q2, 2024 Results on Nov 09, 2023Nipro Corporation announced that they will report Q2, 2024 results on Nov 09, 2023
New Risk • Aug 10New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 106% The company is paying a dividend despite having no free cash flows. Dividend yield: 2.2% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (1.8% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 106% Paying a dividend despite having no free cash flows. Minor Risk Profit margins are more than 30% lower than last year (0.6% net profit margin).
Reported Earnings • Aug 10First quarter 2024 earnings released: EPS: JP¥25.13 (vs JP¥32.34 in 1Q 2023)First quarter 2024 results: EPS: JP¥25.13 (down from JP¥32.34 in 1Q 2023). Revenue: JP¥140.6b (up 9.9% from 1Q 2023). Net income: JP¥4.10b (down 22% from 1Q 2023). Profit margin: 2.9% (down from 4.1% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • May 28Nipro Corporation to Report Q1, 2024 Results on Aug 09, 2023Nipro Corporation announced that they will report Q1, 2024 results on Aug 09, 2023
Reported Earnings • May 14Full year 2023 earnings released: EPS: JP¥28.05 (vs JP¥82.50 in FY 2022)Full year 2023 results: EPS: JP¥28.05 (down from JP¥82.50 in FY 2022). Revenue: JP¥545.2b (up 10% from FY 2022). Net income: JP¥4.57b (down 66% from FY 2022). Profit margin: 0.8% (down from 2.7% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Medical Equipment industry in Germany.
お知らせ • May 13Nipro Corporation, Annual General Meeting, Jun 28, 2023Nipro Corporation, Annual General Meeting, Jun 28, 2023.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥8.50 per share at 2.2% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 29 June 2023. Payout ratio is a comfortable 22% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (4.7%). Higher than average of industry peers (1.7%).
Reported Earnings • Feb 09Third quarter 2023 earnings released: EPS: JP¥4.35 (vs JP¥22.90 in 3Q 2022)Third quarter 2023 results: EPS: JP¥4.35 (down from JP¥22.90 in 3Q 2022). Revenue: JP¥146.0b (up 15% from 3Q 2022). Net income: JP¥710.0m (down 81% from 3Q 2022). Profit margin: 0.5% (down from 2.9% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Germany.
お知らせ • Dec 01Nipro Corporation to Report Q3, 2023 Results on Feb 08, 2023Nipro Corporation announced that they will report Q3, 2023 results on Feb 08, 2023
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: JP¥5.99 (vs JP¥24.54 in 2Q 2022)Second quarter 2023 results: EPS: JP¥5.99 (down from JP¥24.54 in 2Q 2022). Revenue: JP¥132.4b (up 6.7% from 2Q 2022). Net income: JP¥977.0m (down 76% from 2Q 2022). Profit margin: 0.7% (down from 3.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Germany.
Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: JP¥5.99 (vs JP¥24.54 in 2Q 2022)Second quarter 2023 results: EPS: JP¥5.99 (down from JP¥24.54 in 2Q 2022). Revenue: JP¥132.4b (up 6.7% from 2Q 2022). Net income: JP¥977.0m (down 76% from 2Q 2022). Profit margin: 0.7% (down from 3.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Medical Equipment industry in Germany.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥13.50 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 06 December 2022. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of German dividend payers (5.1%). Higher than average of industry peers (1.8%).
お知らせ • Aug 28Nipro Corporation to Report Q2, 2023 Results on Nov 09, 2022Nipro Corporation announced that they will report Q2, 2023 results on Nov 09, 2022
Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: JP¥32.34 (vs JP¥20.23 in 1Q 2022)First quarter 2023 results: EPS: JP¥32.34 (up from JP¥20.23 in 1Q 2022). Revenue: JP¥127.9b (up 8.4% from 1Q 2022). Net income: JP¥5.28b (up 60% from 1Q 2022). Profit margin: 4.1% (up from 2.8% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.3%, compared to a 7.4% growth forecast for the industry in Germany.
Reported Earnings • May 13Full year 2022 earnings released: EPS: JP¥82.50 (vs JP¥87.12 in FY 2021)Full year 2022 results: EPS: JP¥82.50 (down from JP¥87.12 in FY 2021). Revenue: JP¥494.8b (up 8.6% from FY 2021). Net income: JP¥13.5b (down 5.3% from FY 2021). Profit margin: 2.7% (down from 3.1% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.7%, compared to a 7.2% growth forecast for the industry in Germany.
お知らせ • May 13Nipro Corporation, Annual General Meeting, Jun 28, 2022Nipro Corporation, Annual General Meeting, Jun 28, 2022.
お知らせ • Apr 08Nipro Corporation to Report Fiscal Year 2022 Results on May 11, 2022Nipro Corporation announced that they will report fiscal year 2022 results on May 11, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.50 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 28 June 2022. Payout ratio is a comfortable 35% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (3.6%). Higher than average of industry peers (1.1%).
Reported Earnings • Feb 09Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥22.90 (down from JP¥30.07 in 3Q 2021). Revenue: JP¥127.2b (up 7.1% from 3Q 2021). Net income: JP¥3.74b (down 24% from 3Q 2021). Profit margin: 2.9% (down from 4.1% in 3Q 2021). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 4.8%, compared to a 12% growth forecast for the industry in Germany.
Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥24.54 (vs JP¥14.99 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥124.1b (up 9.5% from 2Q 2021). Net income: JP¥4.00b (up 64% from 2Q 2021). Profit margin: 3.2% (up from 2.2% in 2Q 2021).
Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.50 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 07 December 2021. Trailing yield: 2.5%. Lower than top quartile of German dividend payers (3.2%). Higher than average of industry peers (0.8%).
お知らせ • Sep 09Nipro Corporation's Ordinary Shares to Be Deleted from Other OTCNipro Corporation's Ordinary Shares will be deleted from other OTC effective from September 8, 2021 due to Inactive Security.
Reported Earnings • Aug 12First quarter 2022 earnings released: EPS JP¥20.23 (vs JP¥18.57 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2022 results: Revenue: JP¥118.0b (up 8.3% from 1Q 2021). Net income: JP¥3.30b (up 8.9% from 1Q 2021). Profit margin: 2.8% (in line with 1Q 2021).
Reported Earnings • May 14Full year 2021 earnings released: EPS JP¥87.12 (vs JP¥75.30 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥455.6b (up 2.9% from FY 2020). Net income: JP¥14.2b (up JP¥26.5b from FY 2020). Profit margin: 3.1% (up from net loss in FY 2020).
お知らせ • Mar 06Nipro Corporation to Report Fiscal Year 2021 Results on May 11, 2021Nipro Corporation announced that they will report fiscal year 2021 results on May 11, 2021
Is New 90 Day High Low • Feb 18New 90-day high: €10.90The company is up 18% from its price of €9.25 on 19 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Medical Equipment industry, which is up 28% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.22 per share.
Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS JP¥30.07 (vs JP¥30.49 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: JP¥118.8b (up 4.2% from 3Q 2020). Net income: JP¥4.90b (down 1.4% from 3Q 2020). Profit margin: 4.1% (down from 4.4% in 3Q 2020).
Analyst Estimate Surprise Post Earnings • Feb 10Revenue misses expectationsRevenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to grow 7.6%, compared to a 14% growth forecast for the Medical Equipment industry in Germany.
お知らせ • Dec 03Nipro Corporation to Report Q3, 2021 Results on Feb 08, 2021Nipro Corporation announced that they will report Q3, 2021 results on Feb 08, 2021
Reported Earnings • Nov 17Second quarter 2021 earnings released: EPS JP¥14.99The company reported a poor second quarter result with weaker earnings and profit margins, although revenues were flat. Second quarter 2021 results: Revenue: JP¥113.3b (flat on 2Q 2020). Net income: JP¥2.44b (down 21% from 2Q 2020). Profit margin: 2.2% (down from 2.7% in 2Q 2020). The decrease in margin was driven by higher expenses.
Analyst Estimate Surprise Post Earnings • Nov 17Revenue misses expectationsRevenue missed analyst estimates by 5.6%. Over the next year, revenue is forecast to grow 7.2%, compared to a 13% growth forecast for the Medical Equipment industry in Germany.
Reported Earnings • Nov 11Second quarter 2021 earnings released: EPS JP¥14.99The company reported a poor second quarter result with weaker earnings and profit margins, although revenues were flat. Second quarter 2021 results: Revenue: JP¥113.3b (flat on 2Q 2020). Net income: JP¥2.44b (down 21% from 2Q 2020). Profit margin: 2.2% (down from 2.7% in 2Q 2020). The decrease in margin was driven by higher expenses.
Is New 90 Day High Low • Nov 11New 90-day high: €11.50The company is up 21% from its price of €9.50 on 13 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Medical Equipment industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.26 per share.
Is New 90 Day High Low • Oct 27New 90-day low: €8.85The company is down 7.0% from its price of €9.50 on 28 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.45 per share.
お知らせ • Aug 23Nipro Corporation to Report Q2, 2021 Results on Nov 09, 2020Nipro Corporation announced that they will report Q2, 2021 results on Nov 09, 2020